<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Oral Investig</journal-id><journal-id journal-id-type="iso-abbrev">Clin Oral Investig</journal-id><journal-title-group><journal-title>Clinical Oral Investigations</journal-title></journal-title-group><issn pub-type="ppub">1432-6981</issn><issn pub-type="epub">1436-3771</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5632344</article-id><article-id pub-id-type="publisher-id">2062</article-id><article-id pub-id-type="doi">10.1007/s00784-017-2062-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Bone resorptive activity in symptomatic and asymptomatic apical lesions of endodontic origin</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Salinas-Mu&#x000f1;oz</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Garrido-Flores</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Baeza</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Huam&#x000e1;n-Chipana</surname><given-names>P.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a-Sesnich</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bologna</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Vernal</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8289-7314</contrib-id><name><surname>Hern&#x000e1;ndez</surname><given-names>M.</given-names></name><address><phone>56229781808</phone><email>mhernandezrios@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Laboratory of Periodontal Biology, Faculty of Dentistry, </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Department of Conservative Dentistry, Faculty of Dentistry, </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121657640</institution-id><institution-id institution-id-type="GRID">grid.11630.35</institution-id><institution>Molecular Pathology Area, School of Dentistry, </institution><institution>Universidad de la Rep&#x000fa;blica UDELAR, </institution></institution-wrap>Montevideo, Uruguay </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.441837.d</institution-id><institution>Dentistry Unit, Faculty of Health Sciences, </institution><institution>Universidad Aut&#x000f3;noma de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Department of Oral Pathology and Medicine, Faculty of Dentistry, </institution><institution>Universidad de Chile, </institution></institution-wrap>Av. Sergio Livingstone 943, Independencia, Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>6</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><volume>21</volume><issue>8</issue><fpage>2613</fpage><lpage>2618</lpage><history><date date-type="received"><day>5</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">The aim of this study is to assess the levels and diagnostic accuracy of a set of bone resorption biomarkers, including TRAP-5, RANKL, and OPG in symptomatic and asymptomatic apical lesions and controls.</p></sec><sec><title>Materials and methods</title><p id="Par2">Apical tissues from symptomatic and asymptomatic apical periodontitis patients and periodontal ligaments from healthy teeth extracted for orthodontic reasons were processed for tissue homogenization and the levels of TRAP-5, RANKL, and OPG were determined by multiplex assay. Marker levels were analyzed by Kruskal Wallis test, and diagnostic accuracy was analyzed with ROC curves.</p></sec><sec><title>Results</title><p id="Par3">Higher levels of RANKL, OPG, and RANKL/OPG ratio were determined in both types of apical lesions compared to healthy periodontal ligament, whereas higher TRAP-5 levels were found only in symptomatic apical lesions (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). OPG, RANKL, and RANKL/OPG ratio showed diagnostic potential to identify apical lesions versus healthy controls (AUC&#x000a0;=&#x000a0;0.69, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05); while TRAP-5 showed a potential to discriminate symptomatic versus asymptomatic apical periodontitis (AUC =&#x000a0;0.71, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) and healthy controls (AUC&#x000a0;=&#x000a0;0.83, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05).</p></sec><sec><title>Conclusions</title><p id="Par4">Apical lesions showed higher RANKL and OPG levels than healthy tissues. TRAP-5 levels were the highest in symptomatic apical lesions, suggesting that these represent a progressive state, and showed diagnostic potential.</p></sec><sec><title>Clinical relevance</title><p id="Par5">Clinically symptomatic apical periodontitis might represent biologically progressive apical lesions based on TRAP5 levels. TRAP5 has diagnostic potential to identify these lesions, representing a candidate prognostic biomarker.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Symptomatic</kwd><kwd>Asymptomatic periapical periodontitis</kwd><kwd>Bone resorption</kwd><kwd>Biomarkers</kwd><kwd>TRAP</kwd><kwd>RANKL</kwd><kwd>OPG</kwd></kwd-group><funding-group><award-group><funding-source><institution>FONDECYT</institution></funding-source><award-id>1120138 and 1160741</award-id><principal-award-recipient><name><surname>Hern&#x000e1;ndez</surname><given-names>M.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">Apical periodontitis originates from host&#x02019;s immune response to a dominant Gram-negative anaerobic biofilm localized inside the root canal system of the tooth and their respective by-products. Given the inability to eliminate bacteria, the host attempts to localize the infection and prevent further dissemination at the expense of apical tissue breakdown that results in the formation of an osteolytic apical lesion (AL), the hallmark of chronic forms of apical periodontitis [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par7">AL is heterogeneous from a clinical point of view depending on its association with clinical symptoms, being either symptomatic apical periodontitis (SAP) or asymptomatic apical periodontitis (AAP) [<xref ref-type="bibr" rid="CR2">2</xref>]. This clinical variability is expected to depend on the dynamic balance between bacterial consortia and the host&#x02019;s response [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Recent studies support that symptomatic apical periodontitis associates with changes in bacterial load and diversity [<xref ref-type="bibr" rid="CR4">4</xref>], as well as host&#x02019;s immune response, involving interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-&#x003b1;, and matrix metalloproteinase (MMP)-9, respectively [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. Although the clinical diagnosis of symptomatic apical periodontitis is straightforward, its biologic significance remains to be known.</p><p id="Par8">Osteoclasts are the final cellular effectors of bone resorption, determining progression versus healing processes in AL. Osteoclast differentiation and activation from its monocytic precursors is regulated in part through the balance between the receptor activator of nuclear factor &#x003ba;B (RANK), its ligand (RANKL), and its decoy receptor, osteoprotegerin (OPG). Accordingly, significantly higher RANKL levels have been reported in AL compared with healthy tissues [<xref ref-type="bibr" rid="CR9">9</xref>]. RANKL/OPG ratio has also been proposed as an indicator of AL progression [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Tartrate-resistant acid phosphatase (TRAP)-5 on the other hand, is an enzyme released along with bone matrix degradation products by active osteoclasts, representing a direct biomarker of osteoclastic activity and bone resorption [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par9">Higher levels of TRAP-5 are associated with the progression of bone destructive diseases; there is a current need to identify biomarkers for AL progression [<xref ref-type="bibr" rid="CR18">18</xref>]; however, up to now there are no clinical studies linking TRAP-5 with apical periodontitis [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Furthermore, bone resorptive dynamics in symptomatic and asymptomatic states of apical periodontitis remain unknown [<xref ref-type="bibr" rid="CR7">7</xref>]. We aimed to assess the levels and diagnostic accuracy of a set of bone resorption biomarkers in AL from patients with clinical diagnoses of SAP, AAP, and healthy periodontal ligaments as controls, including TRAP-5, RANKL, and OPG.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Materials</title><p id="Par10">Tris-HCl pH 7.5, NaCl, CaCl<sub>2</sub>, and Triton X-100 were purchased from Sigma-Aldrich (St Louis, MO, USA) for homogenization buffer preparation. EDTA-free proteinase inhibitor cocktail was purchased from Roche Diagnostics GmbH (Mannheim, Germany). A Milliplex MAP multiplex assay panel (human cancer/metastasis biomarker magnetic bead) and human bone RANKL single-plex panel was obtained from Millipore, Merck KGaA (Darmstadt, Germany).</p></sec><sec id="Sec4"><title>Methods</title><p id="Par11">Patients who consulted at the Clinic of Oral Surgery, School of Dentistry, University of Chile, Santiago, Chile, were enrolled if they had a clinical diagnosis of either SAP or AAP in the presence of an apical lesion detected by apical radiography (&#x0003e;2&#x000a0;mm diameter) caused by dental caries in teeth with a clinical diagnosis of nonvital pulp, according to previously defined criteria [<xref ref-type="bibr" rid="CR3">3</xref>]. Periodontal ligaments obtained from healthy premolars extracted for orthodontic reasons were used as controls as previously described [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Exclusion criteria included systemic illness or previous antibiotics or nonsteroidal anti-inflammatory treatment during a 6-months period before the study [<xref ref-type="bibr" rid="CR23">23</xref>]. All procedures were performed in accordance with the ethical standards of the institutional research and ethics committee and with the Helsinki declaration. The investigation protocol was clearly explained to all the participants of this study. Each participant signed an informed consent or corresponding forms for their legal guardians in case of underage patients after the risks and benefits of participation were described. A total of 52 apical lesions from patients with SAP (<italic>n</italic>&#x000a0;=&#x000a0;17) and AAP (<italic>n</italic>&#x000a0;=&#x000a0;35), and periodontal ligament samples from healthy volunteers (<italic>n</italic>&#x000a0;=&#x000a0;24) were obtained. After tooth extraction, apical lesions and healthy periodontal ligaments were extracted by surgical separation from the tooth surface with curettes and then stored at &#x02212;20&#x000a0;&#x000b0;C until processed for tissue homogenization and multiplex assay.</p><sec id="Sec5"><title>Tissue homogenates and multiplex assay</title><p id="Par12">After thawing, tissue samples from AL (<italic>n</italic>&#x000a0;=&#x000a0;52) and control periodontal ligaments (<italic>n</italic>&#x000a0;=&#x000a0;24) were weighted. Protein extracts were obtained by manual homogenization in 50&#x000a0;mM Tris-HCl pH 7.5, 0.2&#x000a0;mM NaCl, 5&#x000a0;mM CaCl<sub>2</sub>, and 0.01% Triton X-100 (Sigma-Aldrich, St Louis, MO) buffer adding EDTA-free proteinase inhibitor cocktail (Roche Diagnostics GmbH, Mannheim, Germany) in a constant ratio of 10:1&#x000a0;&#x003bc;L of buffer per milligram of weighted tissue; centrifuged at 10,000&#x000d7;<italic>g</italic> for 6&#x000a0;min at 4&#x000a0;&#x000b0;C and stored at &#x02212;80&#x000a0;&#x000b0;C until further analysis with Milliplex MAP multiplex assays (human cancer/metastasis biomarker magnetic bead and human bone RANKL single-plex panels, Millipore, Merck KGaA, Darmstadt, Germany), according to the manufacturer&#x02019;s instructions. Data was read through a Luminex platform (Magpix, Millipore, St Charles, MO, USA), and analyzed with the MILLIPLEX AnalystR software (ViageneTech, Carlisle, MA, USA).</p></sec><sec id="Sec6"><title>Statistical analyses</title><p id="Par13">Comparisons of TRAP-5, RANKL, and OPG levels between SAP and AAP and controls were analyzed with ANOVA or Kruskal Wallis test using STATA V.11 (StataCorp, College Station, TX, USA), according to data distribution. The evaluation of the diagnostic accuracy of the biomarkers was performed through the construction of ROC curves using SPSS19 software (IBM&#x000ae; Company, Armork, NY, USA) by calculating the area under the curve (AUC). The optimal cut-off points to estimate the highest sensitivity and specificity altogether were assessed by Youden&#x02019;s index. A <italic>p</italic> value &#x0003c;0.05 was considered statistically significant.</p></sec></sec></sec><sec id="Sec7"><title>Results</title><p id="Par14">Controls, asymptomatic apical periodontitis and symptomatic apical periodontitis groups had a mean age of 13.7, 50.1, and 46.5&#x000a0;years and 7, 12, and 11 were women, respectively. No smokers were reported in the controls, whereas there were six smokers in each apical periodontitis group. Regarding biomarker levels (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), significantly higher levels of TRAP-5 were observed in SAP in comparison to AAP and healthy controls (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05), and with no differences between the latter two groups. The levels of RANKL, OPG, and the RANKL/OPG ratio were significantly higher in AAP and SAP groups compared with healthy controls (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05), and no differences were found between both apical periodontitis groups.<fig id="Fig1"><label>Fig. 1</label><caption><p>Bone resorption biomarkers levels in healthy controls, AAP and SAP. Control: healthy periodontal ligaments; <italic>AAP</italic> asymptomatic apical periodontitis; <italic>SAP</italic> symptomatic apical periodontitis; <italic>TRAP5</italic> tartrate-resistant acid phosphatase-5; <italic>RANKL</italic> receptor activator for nuclear factor &#x003ba;B ligand; <italic>OPG</italic> osteoprotegerin; <italic>RANKL/OPG</italic> ratio between RANKL and OPG. <italic>Bars</italic> and <italic>asterisks</italic> represent significant (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) pairwise comparisons (ANOVA and Tukey test for TRAP-5 and Kruskal Wallis test for RANKL, OPG, and RANKL/OPG ratio)</p></caption><graphic xlink:href="784_2017_2062_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par15">The diagnostic performance of biomarkers is illustrated with ROC curves (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a, b, c) and their respective values are presented in Table <xref rid="Tab1" ref-type="table">1</xref>a, b, c. RANKL, OPG, and RANKL/OPG demonstrated statistically significant (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) diagnostic accuracy to identify AAP versus healthy controls, where the highest performance corresponded to RANKL (area under the curve =0.77, 95% CI 0.65&#x02013;0.89), [Fig. <xref rid="Fig2" ref-type="fig">2</xref>a and Table <xref rid="Tab1" ref-type="table">1</xref>a ]. Optimal cut-off points were obtained for each marker by using Youden&#x02019;s index. OPG showed the best performance, with a sensitivity of 80% and a specificity of 69% at a cut-off point of 50&#x000a0;pg/mL, followed by RANKL and RANKL/OPG ratio.<fig id="Fig2"><label>Fig. 2</label><caption><p>ROC curves for the diagnosis of AAP versus controls (<bold>a</bold>), SAP versus controls (<bold>b</bold>), and AAP versus SAP (<bold>c</bold>). <italic>AAP</italic> asymptomatic apical periodontitis; <italic>SAP</italic> symptomatic apical periodontitis; <italic>y</italic> axis: sensitivity, <italic>x</italic> axis: 1-specificity. Lines: <italic>blue</italic> tartrate-resistant acid phosphatase-5 (TRAP), <italic>green</italic> receptor activator for nuclear factor &#x003ba;B ligand (RANKL), <italic>gray</italic> osteoprotegerin (OPG), <italic>purple</italic> ratio between RANKL, and OPG, <italic>yellow</italic> reference line</p></caption><graphic xlink:href="784_2017_2062_Fig2_HTML" id="MO2"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Accuracy of biological markers for the diagnosis of AA versus controls (a), SAP versus controls (b) and AAP versus SAP (c)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Biomarker</th><th>Cut-off</th><th>Sensitivity</th><th>Specificity</th><th>Accuracy (AUC, CI)</th><th>
<italic>p</italic>
</th></tr></thead><tbody><tr><td colspan="6">(a)</td></tr><tr><td>&#x02003;TRAP-5</td><td>8.45&#x000a0;ng/mL</td><td>0.57</td><td>0.58</td><td>0.61 (0.47&#x02013;0.75)</td><td>
<italic>0.143</italic>
</td></tr><tr><td>&#x02003;RANKL</td><td>122.00&#x000a0;pg/mL</td><td>0.66</td><td>0.85</td><td>0.77 (0.65&#x02013;0.89)</td><td>
<italic>&#x0003c;0.0001</italic>
</td></tr><tr><td>&#x02003;OPG</td><td>50.0&#x000a0;pg/mL</td><td>0.80</td><td>0.69</td><td>0.82 (0.71&#x02013;0.93)</td><td>
<italic>&#x0003c;0.0001</italic>
</td></tr><tr><td>&#x02003;RANKL/OPG</td><td>1.05</td><td>0.69</td><td>0.66</td><td>0.70 (0.57&#x02013;0.83)</td><td>
<italic>0.009</italic>
</td></tr><tr><td colspan="6">(b)</td></tr><tr><td>&#x02003;TRAP-5</td><td>12.48&#x000a0;ng/mL</td><td>0.71</td><td>1.00</td><td>0.83 (0.68&#x02013;0.98)</td><td>
<italic>&#x0003c;0.0001</italic>
</td></tr><tr><td>&#x02003;RANKL</td><td>90.64&#x000a0;pg/mL</td><td>0.77</td><td>0.69</td><td>0.83 (0.71&#x02013;0.95)</td><td>
<italic>&#x0003c;0.0001</italic>
</td></tr><tr><td>&#x02003;OPG</td><td>51.50&#x000a0;pg/mL</td><td>0.59</td><td>0.69</td><td>0.69 (0.53&#x02013;0.86)</td><td>
<italic>0.035</italic>
</td></tr><tr><td>&#x02003;RANKL/OPG</td><td>0.99</td><td>0.94</td><td>0.65</td><td>0.82 (0.70&#x02013;0.95)</td><td>
<italic>&#x0003c;0.0001</italic>
</td></tr><tr><td colspan="6">(c)</td></tr><tr><td>&#x02003;TRAP-5</td><td>12.54&#x000a0;ng/mL</td><td>0.73</td><td>0.80</td><td>0.71 (0.54&#x02013;0.89)</td><td>
<italic>0.017</italic>
</td></tr><tr><td>&#x02003;RANKL</td><td>170.5&#x000a0;pg/mL</td><td>0.53</td><td>0.57</td><td>0.51 (0.34&#x02013;0.68)</td><td>0.92</td></tr><tr><td>&#x02003;OPG</td><td>70.50&#x000a0;pg/mL</td><td>0.40</td><td>0.60</td><td>0.35 (0.16&#x02013;0.54)</td><td>0.10</td></tr><tr><td>&#x02003;RANKL/OPG</td><td>2.40</td><td>0.73</td><td>0.51</td><td>0.61 (0.45&#x02013;0.77)</td><td>0.22</td></tr></tbody></table><table-wrap-foot><p>
<italic>AAP</italic> asymptomatic apical periodontitis; <italic>SAP</italic> symptomatic apical periodontitis; <italic>AUC</italic> area under the curve; <italic>CI</italic> confidence interval of 95%; <italic>TRAP5</italic> tartrate-resistant acid phosphatase-5; <italic>RANKL</italic> receptor activator for nuclear factor &#x003ba;B ligand; <italic>OPG</italic> osteoprotegerin; <italic>RANKL/OPG</italic> ratio between RANKL and OPG</p><p>
<italic>p</italic>&#x0003c;0.05</p></table-wrap-foot></table-wrap>
</p><p id="Par16">In the construction of ROC curves for the diagnosis of SAP versus healthy controls [Fig. <xref rid="Fig2" ref-type="fig">2</xref>b and Table <xref rid="Tab1" ref-type="table">1</xref>b], TRAP-5 (AUC&#x000a0;=&#x000a0;0.83, 95% CI 0.68&#x02013;0.98), and RANKL (AUC&#x000a0;=&#x000a0;0.83, 95% CI 0.71&#x02013;0.95) were the markers with the highest accuracy, followed by RANKL/OPG ratio and OPG (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). According to Youden&#x02019;s index, TRAP-5 showed a sensitivity of 71%, a specificity of 100%, at a cut-off point of 12.48&#x000a0;ng/mL, followed by RANKL with a sensitivity of 77% and a specificity of 69% at a cut-off point of 90.64&#x000a0;pg/mL.</p><p id="Par17">TRAP-5 (AUC&#x000a0;=&#x000a0;0.71, 95% CI 0.54&#x02013;0.89) was the only biomarker that showed potential to discriminate between SAP and AAP [Fig. <xref rid="Fig2" ref-type="fig">2</xref>c) and Table <xref rid="Tab1" ref-type="table">1</xref>c, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05]. TRAP-5 showed a sensitivity of 73% and a specificity of 80% at a cut-off point of 12.54&#x000a0;ng/mL.</p></sec><sec id="Sec8"><title>Discussion</title><p id="Par18">AL results from an imbalanced osteoclastic activity induced by the immuno-inflammatory response to endodontic bacterial infection [<xref ref-type="bibr" rid="CR24">24</xref>]. Clinically symptomatic ALs have been suggested to represent an immunologically active stage of the disease [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], but up to now, bone resorptive activity had not been established. In the present study, we assessed the levels of bone resorption markers in symptomatic and asymptomatic AL and healthy periodontal ligament as controls and found statistically significant higher levels of RANKL and OPG in both types of apical lesions compared to healthy periodontal ligament, while higher TRAP-5 levels were found only in symptomatic AL, suggesting that the later represent progressive lesions. TRAP-5 had diagnostic potential for SAP, representing a potentially useful candidate biomarker for apical periodontitis progression.</p><p id="Par19">Bone resorption is a multistep process where RANK/RANKL/OPG pathway and TRAP-5 play key roles. Through binding RANK, RANKL is among the key osteolytic cytokines that promote osteoclast maturation and activation. OPG on the other hand, is a decoy receptor that prevents the coupling of RANK to RANKL [<xref ref-type="bibr" rid="CR10">10</xref>]. Unlike the RANKL/RANK axis, which might either result or not in osteoclast differentiation depending on the OPG levels, TRAP-5 is an enzyme released along with bone matrix degradation products by active osteoclasts representing a direct biomarker of osteoclastic activity and bone resorption [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par20">In the present study the levels of RANKL, OPG and RANKL/OPG ratio were significantly higher in symptomatic and asymptomatic apical lesions versus healthy controls, whereas no significant differences were found between both lesion types. Previous reports associate high levels of RANKL and OPG with apical lesions [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In line with our results, a recent report showed no differences in RANKL and OPG levels between asymptomatic and symptomatic apical lesions, whereas a significantly higher number of gram-negative bacteria along with a positive correlation with OPG were found in the later [<xref ref-type="bibr" rid="CR26">26</xref>]. Whereas the participants showed an homogeneous distribution by gender, an intrinsic methodologic drawback for including healthy periodontal ligament as controls is the age difference among healthy and AP groups, although it represents the closest histophysiologic counterpart for ALs in humans [<xref ref-type="bibr" rid="CR22">22</xref>]. Accordingly, higher mRNA expression levels were found for RANKL and OPG in apical granulomas versus periodontal ligaments [<xref ref-type="bibr" rid="CR10">10</xref>]. Recently, RANKL was identified at higher levels in apical exudates from asymptomatic apical periodontitis compared to irreversible pulpitis, whereas OPG levels remained mostly undetectable [<xref ref-type="bibr" rid="CR27">27</xref>]. So far, there are no previous studies that associate the RANKL/OPG levels with the clinical status in AP. The increased levels of RANKL, OPG, and RANKL/OPG ratio in ALs suggest that these lesions display an imbalance towards osteoclast differentiation, though it might not necessarily result in higher osteolysis [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Based on our results, these markers did not differentiate between symptomatic and asymptomatic apical lesions.</p><p id="Par21">TRAP-5 levels were significantly higher in symptomatic apical lesions compared with asymptomatic lesions and healthy controls, while no differences were found between asymptomatic lesions and controls. TRAP-5 has been proposed to be the most reliable marker of bone resorptive activity. Clinical studies, as well as animal and in vitro experimental models, demonstrate that elevated levels of TRAP-5 can be more specifically explained by an increase in the activity of osteoclasts [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Accordingly, studies conducted in animal models demonstrate that bone resorption rate is significantly higher during the acute stage of apical periodontitis, compared to its chronic phase, where it becomes slower to finally achieve stabilization [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par22">Bone resorption and RANKL production by several cell types is synergistically induced by IL-1, IL-6, and TNF-&#x003b1;. In line with our results, clinical studies report significantly higher levels of these cytokines in apical lesions versus pulp tissue controls and symptomatic versus asymptomatic apical lesions [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Despite the RANKL/OPG ratio has been proposed as an indicator of progression or stability of asymptomatic lesions [<xref ref-type="bibr" rid="CR10">10</xref>], osteolytic cytokines are redundant. TNF-&#x003b1; and IL-1 can also stimulate osteoclast differentiation via RANKL/RANK-independent mechanisms [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], implicating that osteoclastogenesis is only partially accounted by the RANKL/RANK axis. Altogether, these antecedents suggest that inflammation enhances osteoclast differentiation in periapical lesions via RANKL/OPG, but only symptomatic lesions might truly represent an active stage, as reflected by concomitantly elevated RANKL/OPG ratio and TRAP-5 levels. Based on previous reports, it is possible that activation pathways other than RANKL might be induced in symptomatic lesions, resulting in exacerbated bone resorption. The detection of RANKL, OPG, and TRAP at lower levels in healthy periodontal ligament on the other hand might reflect bone homeostasis.</p><p id="Par23">The diagnostic accuracy of OPG, RANKL, and RANKL/OPG ratio showed potential to identify apical lesions versus healthy controls, but failed to discriminate between AAP and SAP. Thus, OPG and RANKL could be useful in the diagnosis of apical periodontitis; however, they do not differentiate between its clinical forms. TRAP-5 on the other hand proved to have the highest diagnostic accuracy to discriminate SAP from AAP and healthy controls, presenting potential as a marker for progressive lesions. Accordingly, TRAP levels also demonstrated diagnostic precision to identify marginal chronic periodontitis in a recent study [<xref ref-type="bibr" rid="CR15">15</xref>]. Currently, apical diagnosis is based solely on clinical and radiological parameters, but they fail to predict treatment outcome in the short term. Thus, TRAP-5 screening in a noninvasive approach might have potential as biomarker for progressive AL to aid clinical decisions in endodontic and restorative procedures in oral fluid samples, such as gingival crevicular fluid, saliva, or in apical exudates during endodontic treatment [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In fact, TRAP levels have already shown a good performance to identify chronic periodontitis in gingival crevicular fluid [<xref ref-type="bibr" rid="CR15">15</xref>]. Future prospective studies are needed to assess its usefulness as a predictive marker.</p></sec><sec id="Sec9"><title>Conclusions</title><p id="Par24">Apical lesions showed higher RANKL and OPG levels than healthy tissues and TRAP-5 levels were the highest in symptomatic apical lesions, suggesting that the later represents a progressive disease state that can be identified by TRAP-5.</p></sec></body><back><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p id="Par25">The authors declare that they have no conflict of interest.</p></sec><sec id="FPar2"><title>Funding</title><p id="Par26">The work was supported by the National Fund for Scientific and Technologic Development (FONDECYT), Chile # 1120138 and 1160741.</p></sec><sec id="FPar3"><title>Ethical approval</title><p id="Par27">This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.</p></sec><sec id="FPar4"><title>Informed consent</title><p id="Par28">Informed consent was obtained from all individual participants included in the study.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hargreaves</surname><given-names>KM</given-names></name><name><surname>Goodis</surname><given-names>HE</given-names></name><name><surname>Tay</surname><given-names>FR</given-names></name><name><surname>Seltzer</surname><given-names>S</given-names></name></person-group><source>Seltzer and Bender&#x02019;s dental pulp</source><year>2012</year><publisher-loc>Hanover Park</publisher-loc><publisher-name>Quintessence Pub</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>AAE</collab></person-group><article-title>Consensus Conference Recommended Diagnostic Terminology</article-title><source>J Endod</source><year>2009</year><volume>35</volume><issue>12</issue><fpage>1634</fpage><pub-id pub-id-type="doi">10.1016/j.joen.2009.09.035</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutmann</surname><given-names>JL</given-names></name><name><surname>Baumgartner</surname><given-names>JC</given-names></name><name><surname>Gluskin</surname><given-names>AH</given-names></name><name><surname>Hartwell</surname><given-names>GR</given-names></name><name><surname>Walton</surname><given-names>RE</given-names></name></person-group><article-title>Identify and define all diagnostic terms for periapical/periradicular health and disease states</article-title><source>J Endod</source><year>2009</year><volume>35</volume><fpage>1658</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1016/j.joen.2009.09.028</pub-id><?supplied-pmid 19932340?><pub-id pub-id-type="pmid">19932340</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buonavoglia</surname><given-names>A</given-names></name><name><surname>Latronico</surname><given-names>F</given-names></name><name><surname>Pirani</surname><given-names>C</given-names></name><name><surname>Greco</surname><given-names>MF</given-names></name><name><surname>Corrente</surname><given-names>M</given-names></name><name><surname>Prati</surname><given-names>C</given-names></name></person-group><article-title>Symptomatic and asymptomatic apical periodontitis associated with red complex bacteria: clinical and microbiological evaluation</article-title><source>Odontology</source><year>2013</year><volume>101</volume><fpage>84</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/s10266-011-0053-y</pub-id><?supplied-pmid 22143381?><pub-id pub-id-type="pmid">22143381</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>WW</given-names></name><name><surname>Li</surname><given-names>KL</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Fraser-Liggett</surname><given-names>CM</given-names></name><name><surname>Fouad</surname><given-names>AF</given-names></name></person-group><article-title>Microbial transformation from normal oral microbiota to acute endodontic infections</article-title><source>BMC Genomics</source><year>2012</year><volume>13</volume><fpage>345</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-13-345</pub-id><?supplied-pmid 22839737?><pub-id pub-id-type="pmid">22839737</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>GM</given-names></name><name><surname>El-Baz</surname><given-names>AA</given-names></name><name><surname>Hashem</surname><given-names>AA</given-names></name><name><surname>Shalaan</surname><given-names>AK</given-names></name></person-group><article-title>Expression levels of matrix metalloproteinase-9 and gram-negative bacteria in symptomatic and asymptomatic periapical lesions</article-title><source>J Endod</source><year>2013</year><volume>39</volume><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.joen.2012.11.009</pub-id><?supplied-pmid 23522533?><pub-id pub-id-type="pmid">23522533</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prso</surname><given-names>IB</given-names></name><name><surname>Kocjan</surname><given-names>W</given-names></name><name><surname>Simic</surname><given-names>H</given-names></name><name><surname>Brumini</surname><given-names>G</given-names></name><name><surname>Pezelj-Ribaric</surname><given-names>S</given-names></name><name><surname>Borcic</surname><given-names>J</given-names></name><name><surname>Ferreri</surname><given-names>S</given-names></name><name><surname>Karlovic</surname><given-names>IM</given-names></name></person-group><article-title>Tumor necrosis factor-alpha and interleukin 6 in human periapical lesions</article-title><source>Mediat Inflamm</source><year>2007</year><volume>2007</volume><fpage>38210</fpage></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakovljevic</surname><given-names>A</given-names></name><name><surname>Knezevic</surname><given-names>A</given-names></name><name><surname>Karalic</surname><given-names>D</given-names></name><name><surname>Soldatovic</surname><given-names>I</given-names></name><name><surname>Popovic</surname><given-names>B</given-names></name><name><surname>Milasin</surname><given-names>J</given-names></name><name><surname>Andric</surname><given-names>M</given-names></name></person-group><article-title>Pro-inflammatory cytokine levels in human apical periodontitis: correlation with clinical and histological findings</article-title><source>Aust Endod J</source><year>2015</year><volume>41</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/aej.12072</pub-id><?supplied-pmid 25163634?><pub-id pub-id-type="pmid">25163634</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernal</surname><given-names>R</given-names></name><name><surname>Dezerega</surname><given-names>A</given-names></name><name><surname>Dutzan</surname><given-names>N</given-names></name><name><surname>Chaparro</surname><given-names>A</given-names></name><name><surname>Leon</surname><given-names>R</given-names></name><name><surname>Chandia</surname><given-names>S</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>Gamonal</surname><given-names>J</given-names></name></person-group><article-title>RANKL in human periapical granuloma: possible involvement in periapical bone destruction</article-title><source>Oral Dis</source><year>2006</year><volume>12</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1111/j.1601-0825.2005.01191.x</pub-id><?supplied-pmid 16700737?><pub-id pub-id-type="pmid">16700737</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>RGTP</given-names></name><name><surname>Letra</surname><given-names>A</given-names></name><name><surname>Bramante</surname><given-names>CM</given-names></name><name><surname>Campanelli</surname><given-names>AP</given-names></name><name><surname>de C&#x000e1;ssia Figueira</surname><given-names>R</given-names></name><name><surname>Sogayar</surname><given-names>MC</given-names></name><name><surname>Granjeiro</surname><given-names>JM</given-names></name><name><surname>Garlet</surname><given-names>GP</given-names></name></person-group><article-title>Differential patterns of RANKL/OPG expression in human periapical granulomas: possible association with progressive or stable nature of the lesions</article-title><source>J Endod</source><year>2008</year><volume>34</volume><fpage>932</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1016/j.joen.2008.05.002</pub-id><?supplied-pmid 18634923?><pub-id pub-id-type="pmid">18634923</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo-Pires</surname><given-names>AC</given-names></name><name><surname>Francisconi</surname><given-names>CF</given-names></name><name><surname>Biguetti</surname><given-names>CC</given-names></name><name><surname>Cavalla</surname><given-names>F</given-names></name><name><surname>Aranha</surname><given-names>AM</given-names></name><name><surname>Letra</surname><given-names>A</given-names></name><name><surname>Trombone</surname><given-names>AP</given-names></name><name><surname>Faveri</surname><given-names>M</given-names></name><name><surname>Silva</surname><given-names>RM</given-names></name><name><surname>Garlet</surname><given-names>GP</given-names></name></person-group><article-title>Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status</article-title><source>J Appl Oral Sci</source><year>2014</year><volume>22</volume><fpage>336</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1590/1678-775720140140</pub-id><?supplied-pmid 25141207?><pub-id pub-id-type="pmid">25141207</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halleen</surname><given-names>JM</given-names></name></person-group><article-title>Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption</article-title><source>Anticancer Res</source><year>2003</year><volume>23</volume><fpage>1027</fpage><lpage>1029</lpage><?supplied-pmid 12820342?><pub-id pub-id-type="pmid">12820342</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halleen</surname><given-names>JM</given-names></name><name><surname>Tiitinen</surname><given-names>SL</given-names></name><name><surname>Ylipahkala</surname><given-names>H</given-names></name><name><surname>Fagerlund</surname><given-names>KM</given-names></name><name><surname>Vaananen</surname><given-names>HK</given-names></name></person-group><article-title>Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption</article-title><source>Clin Lab</source><year>2006</year><volume>52</volume><fpage>499</fpage><lpage>509</lpage><?supplied-pmid 17078477?><pub-id pub-id-type="pmid">17078477</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janckila</surname><given-names>AJ</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>SZ</given-names></name><name><surname>Yam</surname><given-names>LT</given-names></name></person-group><article-title>Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity</article-title><source>Clin Chem</source><year>2001</year><volume>47</volume><fpage>74</fpage><lpage>80</lpage><?supplied-pmid 11148180?><pub-id pub-id-type="pmid">11148180</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Baeza M, Garrido M, Hernandez-Rios P, Dezerega A, Garcia-Sesnich J, Strauss F, Aitken JP, Lesaffre E, Vanbelle S, Gamonal J et al. (2015) Diagnostic accuracy for apical and chronic periodontitis biomarkers in gingival crevicular fluid: an exploratory study. J Clin Periodontol</mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>FG</given-names></name><name><surname>Soares</surname><given-names>DG</given-names></name><name><surname>Pansani</surname><given-names>TN</given-names></name><name><surname>Turrioni</surname><given-names>AP</given-names></name><name><surname>Scheffel</surname><given-names>DL</given-names></name><name><surname>de Souza Costa</surname><given-names>CA</given-names></name><name><surname>Hebling</surname><given-names>J</given-names></name></person-group><article-title>Effect of LPS treatment on the viability and chemokine synthesis by epithelial cells and gingival fibroblasts</article-title><source>Arch Oral Biol</source><year>2015</year><volume>60</volume><fpage>1117</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2015.04.010</pub-id><?supplied-pmid 26042620?><pub-id pub-id-type="pmid">26042620</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">da Costa TA, Silva MJB, Alves PM, Chica JEL, Barcelos EZ, Giani MAA, Garlet GP, da Silva JS, Rodrigues J&#x000fa;nior V, Rodrigues DBR et al. (2015) Inflammation Biomarkers of Advanced Disease in Nongingival Tissues of Chronic Periodontitis Patients. Mediat Inflamm 2015</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvist</surname><given-names>T</given-names></name><name><surname>van der Sluis</surname><given-names>L</given-names></name></person-group><article-title>Report of the first ESE research meeting&#x02014;17(th) October 2014, Amsterdam, the Netherlands: the relationship between endodontic infections and their treatment with systemic diseases</article-title><source>Int Endod J</source><year>2015</year><volume>48</volume><fpage>913</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1111/iej.12505</pub-id><?supplied-pmid 26336962?><pub-id pub-id-type="pmid">26336962</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halleen</surname><given-names>JM</given-names></name><name><surname>Alatalo</surname><given-names>SL</given-names></name><name><surname>Suominen</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Janckila</surname><given-names>AJ</given-names></name><name><surname>Vaananen</surname><given-names>HK</given-names></name></person-group><article-title>Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption</article-title><source>J Bone Miner Res</source><year>2000</year><volume>15</volume><fpage>1337</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1359/jbmr.2000.15.7.1337</pub-id><?supplied-pmid 10893682?><pub-id pub-id-type="pmid">10893682</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnero</surname><given-names>P</given-names></name></person-group><article-title>New developments in biological markers of bone metabolism in osteoporosis</article-title><source>Bone</source><year>2014</year><volume>66</volume><fpage>46</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2014.05.016</pub-id><?supplied-pmid 24909537?><pub-id pub-id-type="pmid">24909537</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalla</surname><given-names>F</given-names></name><name><surname>Osorio</surname><given-names>C</given-names></name><name><surname>Paredes</surname><given-names>R</given-names></name><name><surname>Valenzuela</surname><given-names>MA</given-names></name><name><surname>Garcia-Sesnich</surname><given-names>J</given-names></name><name><surname>Sorsa</surname><given-names>T</given-names></name><name><surname>Tervahartiala</surname><given-names>T</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name></person-group><article-title>Matrix metalloproteinases regulate extracellular levels of SDF-1/CXCL12, IL-6 and VEGF in hydrogen peroxide-stimulated human periodontal ligament fibroblasts</article-title><source>Cytokine</source><year>2015</year><volume>73</volume><fpage>114</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2015.02.001</pub-id><?supplied-pmid 25748833?><pub-id pub-id-type="pmid">25748833</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalla</surname><given-names>F</given-names></name><name><surname>Reyes</surname><given-names>M</given-names></name><name><surname>Vernal</surname><given-names>R</given-names></name><name><surname>Alvarez</surname><given-names>C</given-names></name><name><surname>Paredes</surname><given-names>R</given-names></name><name><surname>Garcia-Sesnich</surname><given-names>J</given-names></name><name><surname>Infante</surname><given-names>M</given-names></name><name><surname>Farina</surname><given-names>V</given-names></name><name><surname>Barron</surname><given-names>I</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name></person-group><article-title>High levels of CXC ligand 12/stromal cell-derived factor 1 in apical lesions of endodontic origin associated with mast cell infiltration</article-title><source>J Endod</source><year>2013</year><volume>39</volume><fpage>1234</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1016/j.joen.2013.06.020</pub-id><?supplied-pmid 24041383?><pub-id pub-id-type="pmid">24041383</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>M</given-names></name><name><surname>Dezerega</surname><given-names>A</given-names></name><name><surname>Bordagaray</surname><given-names>MJ</given-names></name><name><surname>Reyes</surname><given-names>M</given-names></name><name><surname>Vernal</surname><given-names>R</given-names></name><name><surname>Melgar-Rodriguez</surname><given-names>S</given-names></name><name><surname>Ciuchi</surname><given-names>P</given-names></name><name><surname>Paredes</surname><given-names>R</given-names></name><name><surname>Garcia-Sesnich</surname><given-names>J</given-names></name><name><surname>Ahumada-Montalva</surname><given-names>P</given-names></name><etal/></person-group><article-title>C-reactive protein expression is up-regulated in apical lesions of endodontic origin in association with interleukin-6</article-title><source>J Endod</source><year>2015</year><volume>41</volume><fpage>464</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.joen.2014.12.021</pub-id><?supplied-pmid 25748492?><pub-id pub-id-type="pmid">25748492</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>PN</given-names></name></person-group><article-title>Pathogenesis of apical periodontitis and the causes of endodontic failures</article-title><source>Crit Rev Oral Biol Med</source><year>2004</year><volume>15</volume><fpage>348</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1177/154411130401500604</pub-id><?supplied-pmid 15574679?><pub-id pub-id-type="pmid">15574679</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belibasakis</surname><given-names>GN</given-names></name><name><surname>Rechenberg</surname><given-names>DK</given-names></name><name><surname>Zehnder</surname><given-names>M</given-names></name></person-group><article-title>The receptor activator of NF-kappaB ligand-osteoprotegerin system in pulpal and periapical disease</article-title><source>Int Endod J</source><year>2013</year><volume>46</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2591.2012.02105.x</pub-id><?supplied-pmid 22900632?><pub-id pub-id-type="pmid">22900632</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>E</given-names></name><name><surname>Parolin</surname><given-names>AB</given-names></name><name><surname>Wichnieski</surname><given-names>C</given-names></name><name><surname>Rosa</surname><given-names>EA</given-names></name><name><surname>Silva Neto</surname><given-names>UX</given-names></name><name><surname>Westphalen</surname><given-names>VP</given-names></name><name><surname>Fariniuk</surname><given-names>LF</given-names></name><name><surname>Johann</surname><given-names>AC</given-names></name></person-group><article-title>Expression levels of the receptor activator of NF-&#x003ba;B ligand and osteoprotegerin and the number of gram-negative bacteria in symptomatic and asymptomatic periapical lesions</article-title><source>Arch Oral Biol</source><year>2017</year><volume>73</volume><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2016.10.004</pub-id><?supplied-pmid 27771584?><pub-id pub-id-type="pmid">27771584</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rechenberg</surname><given-names>DK</given-names></name><name><surname>Bostanci</surname><given-names>N</given-names></name><name><surname>Zehnder</surname><given-names>M</given-names></name><name><surname>Belibasakis</surname><given-names>GN</given-names></name></person-group><article-title>Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis</article-title><source>Cytokine</source><year>2014</year><volume>69</volume><fpage>116</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2014.05.014</pub-id><?supplied-pmid 25022970?><pub-id pub-id-type="pmid">25022970</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rissanen</surname><given-names>JP</given-names></name><name><surname>Suominen</surname><given-names>MI</given-names></name><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Halleen</surname><given-names>JM</given-names></name></person-group><article-title>Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model</article-title><source>Calcif Tissue Int</source><year>2008</year><volume>82</volume><fpage>108</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1007/s00223-007-9091-4</pub-id><?supplied-pmid 18084692?><pub-id pub-id-type="pmid">18084692</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stashenko</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>CY</given-names></name><name><surname>Tani-Ishii</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>SM</given-names></name></person-group><article-title>Pathogenesis of induced rat periapical lesions</article-title><source>Oral Surg Oral Med Oral Pathol</source><year>1994</year><volume>78</volume><fpage>494</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/0030-4220(94)90044-2</pub-id><?supplied-pmid 7800381?><pub-id pub-id-type="pmid">7800381</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Jin</surname><given-names>HM</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Song</surname><given-names>I</given-names></name><name><surname>Youn</surname><given-names>BU</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name></person-group><article-title>The mechanism of osteoclast differentiation induced by IL-1</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>1862</fpage><lpage>1870</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803007</pub-id><?supplied-pmid 19587010?><pub-id pub-id-type="pmid">19587010</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Jimi</surname><given-names>E</given-names></name><name><surname>Udagawa</surname><given-names>N</given-names></name><name><surname>Takami</surname><given-names>M</given-names></name><name><surname>Kotake</surname><given-names>S</given-names></name><name><surname>Nakagawa</surname><given-names>N</given-names></name><name><surname>Kinosaki</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name><name><surname>Shima</surname><given-names>N</given-names></name><etal/></person-group><article-title>Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>275</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1084/jem.191.2.275</pub-id><?supplied-pmid 10637272?><pub-id pub-id-type="pmid">10637272</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauricio Garrido</surname><given-names>AD</given-names></name><name><surname>Castro-Mart&#x000ed;nez</surname><given-names>A</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>M</given-names></name></person-group><article-title>Host-dericed biomarkers in gingival crevicular fluid for complementary diagnosis of apical periodontitis</article-title><source>World J Stomatol</source><year>2014</year><volume>3</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.5321/wjs.v3.i2.19</pub-id></element-citation></ref></ref-list></back></article>